Govoptes

HR 586 · Vietnam Veterans Liver Fluke Cancer Study Act

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Introduced
Jan 21, 2025
Latest action
Apr 8, 2025
Sponsor
Rep. Nick LaLota [R-NY-1]
Policy area
Armed Forces and National Security
Cosponsors
8

Summary

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Recent actions

  1. Apr 8, 2025 Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
  2. Apr 7, 2025 Motion to reconsider laid on the table Agreed to without objection.
  3. Apr 7, 2025 On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)
  4. Apr 7, 2025 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
  5. Apr 7, 2025 Considered as unfinished business. (consideration: CR H1441-1442)
  6. Apr 7, 2025 At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  7. Apr 7, 2025 DEBATE - The House proceeded with forty minutes of debate on H.R. 586.
  8. Apr 7, 2025 Considered under suspension of the rules. (consideration: CR H1435-1437)

Votes

Related pages